Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

6.3K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
6.3K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

407
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
407
Group Design02:01

Group Design

9.3K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
9.3K
Random Sampling Method01:09

Random Sampling Method

11.8K
Sampling is a technique to select a portion (or subset) of the larger population and study that portion (the sample) to gain information about the population. Data are the result of sampling from a population. The sampling method ensures that samples are drawn without bias and accurately represent the population. Because measuring the entire population in a study is not practical, researchers use samples to represent the population of interest. Among the various sampling methods used by...
11.8K
Blinding01:11

Blinding

2.9K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.9K
Censoring Survival Data01:09

Censoring Survival Data

689
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
689

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of the somatic landscape and transcriptional profile of breast tumors from 748 Hispanic/Latina women in California.

medRxiv : the preprint server for health sciences·2026
Same author

Identification of Early Symptoms Associated with Subsequent Immune-related Adverse Events in the I-SPY clinical trial.

Research square·2026
Same author

Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical Trial.

JAMA·2025
Same author

PENTAGON (Predicting Clinical Trials in Gynecologic Oncology): A Retrospective Study Assessing Study Design Factors That Affect Enrollment in Gynecologic Cancer Trials.

Cancers·2025
Same author

Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors.

Nature communications·2025
Same author

Independent Increments and Group Sequential Tests.

Statistics in medicine·2025
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
See all related articles

Related Experiment Video

Updated: Apr 30, 2026

Barnes Maze Testing Strategies with Small and Large Rodent Models
12:59

Barnes Maze Testing Strategies with Small and Large Rodent Models

Published on: February 26, 2014

42.8K

Bayesian adaptive randomization in the I-SPY2 sequential multiple assignment randomized trial.

Peter Norwood1, Christina Yau2, Denise Wolf2

  • 1Quantum Leap Healthcare Collaborative, San Francisco, CA 94104, United States.

Biometrics
|April 29, 2026
PubMed
Summary
This summary is machine-generated.

The I-SPY2 trial uses a novel adaptive randomization method to assign patients with locally advanced breast cancer to the most effective treatments. This approach increases the likelihood of patients receiving optimal therapies and improves pathological complete response rates.

Keywords:
Bayesian response-adaptive randomizationbreast cancerprecision oncologysequential multiple assignment randomized trial

More Related Videos

A Tactile Automated Passive-Finger Stimulator TAPS
19:44

A Tactile Automated Passive-Finger Stimulator TAPS

Published on: June 3, 2009

14.9K
Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
13:04

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

Published on: September 19, 2012

11.6K

Related Experiment Videos

Last Updated: Apr 30, 2026

Barnes Maze Testing Strategies with Small and Large Rodent Models
12:59

Barnes Maze Testing Strategies with Small and Large Rodent Models

Published on: February 26, 2014

42.8K
A Tactile Automated Passive-Finger Stimulator TAPS
19:44

A Tactile Automated Passive-Finger Stimulator TAPS

Published on: June 3, 2009

14.9K
Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
13:04

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

Published on: September 19, 2012

11.6K

Area of Science:

  • Oncology
  • Clinical Trials
  • Biostatistics

Background:

  • The I-SPY2 trial is a Phase 2 platform evaluating neoadjuvant treatments for locally advanced breast cancer.
  • It utilizes response-adaptive randomization (RAR) to assign patients to novel agents.
  • Recently, I-SPY2 was reconfigured as a sequential multiple assignment randomized trial (SMART) with up to three therapy stages.

Purpose of the Study:

  • To identify highly efficacious neoadjuvant treatment regimens for locally advanced breast cancer.
  • To develop and implement a Bayesian RAR scheme for a SMART trial.
  • To maximize the number of patients achieving pathological complete response (pCR).

Main Methods:

  • The study employs a sequential multiple assignment randomized trial (SMART) design.
  • A Bayesian response-adaptive randomization (RAR) approach was developed to update randomization probabilities at each stage.
  • Randomization probabilities are updated based on the posterior probability that treatments are part of the optimal regimen.

Main Results:

  • The Bayesian RAR approach resulted in more patients receiving treatment consistent with highly efficacious regimens.
  • The method improved overall within-trial pathological complete response (pCR) rates.
  • Optimal treatment regimes were identified post-trial at rates similar to or exceeding nonadaptive randomization.

Conclusions:

  • The developed Bayesian RAR scheme effectively identifies optimal treatment regimens in the I-SPY2 SMART trial.
  • This adaptive approach enhances patient treatment experience and improves trial-wide pCR rates.
  • The SMART design with Bayesian RAR is a powerful strategy for accelerating the development of effective breast cancer therapies.